Skip to main content

and
  1. No Access

    Article

    Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

    Cytomegalovirus (CMV) infection is a common, potentially life-threatening complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT). We assessed prospectively the safety and efficac...

    M Neuenhahn, J Albrecht, M Odendahl, F Schlott, G Dössinger, M Schiemann in Leukemia (2017)